TP53 and neoplasm: The molecular mechanisms involved in the hypoxic generation of PGCCs, including HIF-1α stabilization, involvement of p53/p47 isoform and cell cycle arrest in G2, point to novel therapeutic targets for the prevention of tumor recurrence and treatment failure in colon cancer.